Patrick Donahue
Chief Executive Officer, Theragnostics Inc.
Healthcare Experts
Theragnostics
Spain
Biography
Pat joined Theragnostics from Blackthorn Associates, LLC, which focuses on technology and market evaluation, development and program management in the fields of nuclear medicine and radiation therapy. Pat has more than 20 years of experience in these fields and counselled international clients in marketing and sales, business development, project management and technology development. As Director of North American Operations for Eckert & Ziegler Eurotope GmbH he established the North American business entity and launched the IGG100 Gallium-68 Generator and Modular-Lab PET tracer synthesis technology product lines. Earlier, he held senior positions at QSA Global, Alliant Medical, and DuPont Radiopharmaceuticals. Pat served on the Society for Nuclear Medicine and Molecular Imaging, Radiopharmaceutical Sciences Council and is a past president of the Boston Chapter of the International Society for Pharmaceutical Engineering. He holds a BS in Chemical Engineering from Worcester Polytechnic Institute, an MBA from Boston University, and is a Registered Professional Engineer.
Research Interest
radiopharmaceutics